FIELD: medicine, physiology, pathophysiology, pharmacology. SUBSTANCE: the end product is isolated from peony roots bark (Paeonia lutea). Roots are peeled, washed with cold water and dried at 36.5-37.5 C for 23-25 h. Dried bark is separated, milled to granular-powder-like state, poured with 40% ethyl alcohol (10 ml of alcohol per 1 g of powder) and infused for 5-7 days in dark. Precipitate is removed and supernatant is brought about to the initial volume with distilled water. After oral administration of the preparation to animals the total fibrinolytic activity is increased by 1.6-fold, activity of plasminogen activator - by 2-fold, activated partial thromboplastin time is increased by 1.4-fold and blood glucose content in development of experimental insulin-dependent diabetes mellitus is decreased. Invention can be used for preparing biologically active preparation showing an anticoagulant effect. EFFECT: broadened assortment of preparations and their spectrum of effects. 3 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING AGENT ELICITING ANTICOAGULANT, FIBRINOLYTIC, ANTIPLATELETIC, ANTITHROMBOTIC AND THROMBOLYTIC EFFECT | 2001 |
|
RU2199331C1 |
ANTIDIABETOGENIC AGENT | 1997 |
|
RU2129435C1 |
ANTICOAGULANT | 1995 |
|
RU2068702C1 |
METHOD OF TREATING DIABETES IN ANIMALS | 2009 |
|
RU2403910C1 |
ANTITHROMBOTIC COMPOSITION ON BASIS OF HEPARIN FOR PERORAL APPLICATION | 2008 |
|
RU2359681C1 |
ANTITHROMBOSIS AGENT | 1997 |
|
RU2138269C1 |
METHOD OF PRODUCING ANTICOAGULATIVE COLLAGENASE INHIBITOR FROM KING CRAB HEPATOPANCREAS | 2009 |
|
RU2403284C1 |
METHOD OF TREATING DIABETES IN MAMMALS AND INTRANASAL PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES IN MAMMALS | 2009 |
|
RU2403909C1 |
AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
APPLICATION OF Pro-Gly-Pro-Leu TETRAPEPTIDE AS AGENT FOR PREVENTION AND TREATMENT OF DIABETES, METHOD FOR PREVENTION AND TREATMENT OF DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETES | 2008 |
|
RU2378005C1 |
Authors
Dates
1999-12-27—Published
1998-12-11—Filed